Processing

Please wait...

Settings

Settings

Goto Application

1. WO2003105839 - USE OF RIBAVIRIN FOR PRODUCING A PHARMACEUTICAL COMPOSITION DIRECTED AGAINST BUNYAVIRIDAE

Publication Number WO/2003/105839
Publication Date 24.12.2003
International Application No. PCT/EP2003/006392
International Filing Date 17.06.2003
IPC
A61K 31/41 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
CPC
A61K 31/41
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
Applicants
  • BIOPARTNERS GMBH [CH]/[CH] (AE, AG, AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NE, NI, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW)
  • SOBEL, Cornelius [DE]/[DE] (UsOnly)
  • POWLES, Ray [GB]/[GB] (UsOnly)
Inventors
  • SOBEL, Cornelius
  • POWLES, Ray
Agents
  • KRAUSS, Jan
Priority Data
102 27 148.818.06.2002DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) VERWENDUNG VON RIBAVIRIN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG GEGEN BUNYAVIRIDAE
(EN) USE OF RIBAVIRIN FOR PRODUCING A PHARMACEUTICAL COMPOSITION DIRECTED AGAINST BUNYAVIRIDAE
(FR) UTILISATION DE RIBAVIRINE POUR LA FABRICATION D'UNE COMPOSITION PHARMACEUTIQUE CONTRE BUNYAVIRIDAE
Abstract
(DE)
Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung eines Patienten, der mit Bunyaviridae infiziert ist, dadurch gekennzeichnet, dass die pharmazeutische Zusammensetzung oral und/oder rektal in komprimierter Form verabreicht wird und eine Verbraucherpackung, dadurch gekennzeichnet, dass sie Informationsmaterial über die Verwendung von Ribavirin und eine pharmazeutische Zusammensetzung, die Ribavirin enthält, in komprimierter Form umfasst.
(EN)
The invention relates to the use of ribavirin for producing a pharmaceutical composition used for treating a patient who is infected with Bunyaviridae. The invention is characterized in that the pharmaceutical composition is administered orally and/or rectally in a compressed form. In addition, a consumer pack is characterized in that it contains both information material pertaining to the use of ribavirin as well as a pharmaceutical composition, which comprises ribavirin while provided in compressed form.
(FR)
L'invention concerne un procédé d'utilisation de ribavirine pour la fabrication d'une composition pharmaceutique destinée au traitement d'un patient infecté par bunyaviridae. Le procédé selon l'invention est caractérisé en ce que ladite composition pharmaceutique est administrée par voie orale ou rectale sous forme de comprimé. L'invention concerne également un emballage utilisateur caractérisé en ce qu'il contient des informations concernant l'utilisation de ribavirine, ainsi qu'une composition pharmaceutique contenant de la ribavirine.
Also published as
Latest bibliographic data on file with the International Bureau